Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Sexually Transmitted Diseases

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 16 articles: HTML format

Single Articles

March 2023
1. MITTELSTADT S, Kelemen O, Admard J, Gschwind A, et al
   Detection of circulating cell-free HPV DNA of 13 HPV types for patients with cervical cancer as potential biomarker to monitor therapy response and to detect relapse.
   Br J Cancer. 2023 Mar 27. doi: 10.1038/s41416-023-02233.
   PubMed     Abstract available
   
   
   
2. GILHAM C, Sargent A, Crosbie EJ, Peto J, et al
   Long-term risks of invasive cervical cancer following HPV infection: follow-up of two screening cohorts in Manchester.
   Br J Cancer. 2023 Mar 23. doi: 10.1038/s41416-023-02227.
   PubMed     Abstract available
   
   
   December 2022
3. COSTA S, Verberckmoes B, Castle PE, Arbyn M, et al
   Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening.
   Br J Cancer. 2022 Dec 14. doi: 10.1038/s41416-022-02094.
   PubMed     Abstract available
   
   
   August 2022
4. AASBO G, Trope A, Nygard M, Christiansen IK, et al
   HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial.
   Br J Cancer. 2022 Aug 23. pii: 10.1038/s41416-022-01954.
   PubMed     Abstract available
   
   
   June 2022
5. HERBST J, Pantel K, Effenberger K, Wikman H, et al
   Clinical applications and utility of cell-free DNA-based liquid biopsy analyses in cervical cancer and its precursor lesions.
   Br J Cancer. 2022 Jun 20. pii: 10.1038/s41416-022-01868.
   PubMed     Abstract available
   
   
   March 2022
6. REBOLJ M, Pesola F, Mathews C, Mesher D, et al
   The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilot.
   Br J Cancer. 2022 Mar 26. pii: 10.1038/s41416-022-01791.
   PubMed     Abstract available
   
   
   November 2021
7. DICK S, Vink FJ, Heideman DAM, Lissenberg-Witte BI, et al
   Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping.
   Br J Cancer. 2021 Nov 6. pii: 10.1038/s41416-021-01614.
   PubMed     Abstract available
   
   
   October 2021
8. MANLEY K, Patel A, Pawade J, Glew S, et al
   The use of biomarkers and HPV genotyping to improve diagnostic accuracy in women with a transformation zone type 3.
   Br J Cancer. 2021 Oct 29. pii: 10.1038/s41416-021-01539.
   PubMed     Abstract available
   
   
   September 2021
9. IDEN M, Tsaih SW, Huang YW, Liu P, et al
   Multi-omics mapping of human papillomavirus integration sites illuminates novel cervical cancer target genes.
   Br J Cancer. 2021 Sep 15. pii: 10.1038/s41416-021-01545.
   PubMed     Abstract available
   
   
   June 2021
10. WAGNER S, Prigge ES, Wuerdemann N, Reder H, et al
    Correction: Evaluation of p16(INK4a) expression as a single marker to select patients with HPV-driven oropharyngeal cancers for treatment de-escalation.
    Br J Cancer. 2021 Jun 10. pii: 10.1038/s41416-021-01457.
    PubMed    
    
    
    March 2021
11. OLIVA M, Schneeberger PHH, Rey V, Cho M, et al
    Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study).
    Br J Cancer. 2021 Mar 10. pii: 10.1038/s41416-020-01253.
    PubMed     Abstract available
    
    
    
12. EINBOND LS, Zhou J, Wu HA, Mbazor E, et al
    A novel cancer preventative botanical mixture, TriCurin, inhibits viral transcripts and the growth of W12 cervical cells harbouring extrachromosomal or integrated HPV16 DNA.
    Br J Cancer. 2021;124:901-913.
    PubMed     Abstract available
    
    
    December 2020
13. PATEL U, Pandey M, Kannan S, Samant TA, et al
    Prognostic and predictive significance of nuclear HIF1alpha expression in locally advanced HNSCC patients treated with chemoradiation with or without nimotuzumab.
    Br J Cancer. 2020;123:1757-1766.
    PubMed     Abstract available
    
    
    November 2020
14. KAMAL M, Lameiras S, Deloger M, Morel A, et al
    Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site.
    Br J Cancer. 2020 Nov 16. pii: 10.1038/s41416-020-01153.
    PubMed     Abstract available
    
    
    October 2020
15. ARROYO MUHR LS, Lagheden C, Lei J, Eklund C, et al
    Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR.
    Br J Cancer. 2020 Oct 6. pii: 10.1038/s41416-020-01111.
    PubMed     Abstract available
    
    
    November 2019
16. SABATINI ME, Chiocca S
    Human papillomavirus as a driver of head and neck cancers.
    Br J Cancer. 2019 Nov 11. pii: 10.1038/s41416-019-0602.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Sexually Transmitted Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: